Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biorestorative Therapies Inc (NQ: BRTX )

1.480 -0.020 (-1.33%)
Streaming Delayed Price Updated: 3:35 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,434
Open 1.530
Bid (Size) 1.480 (3)
Ask (Size) 1.550 (3)
Prev. Close 1.500
Today's Range 1.480 - 1.550
52wk Range 1.030 - 3.670
Shares Outstanding 6,919,919
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial
BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial 
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market
Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market 
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
-13.95%
-13.95%
1 Month
-3.26%
-3.26%
3 Month
-9.20%
-9.20%
6 Month
+19.36%
+19.36%
1 Year
-18.23%
-18.23%

More News

Read More
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Armed With Its Patent Portfolio, BioRestorative Therapies Has Success In The Laboratory And At The Negotiating Table: Is Profitability Close Behind?
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
What's Going On With BioRestorative Therapies Stock?
Via Benzinga
S&P 500 Edges Higher; J.Jill Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Gold Down 1%; Broadcom Shares Jump After Upbeat Results
Via Benzinga
Why BioRestorative Therapies Stock Is Moving Higher Thursday
Via Benzinga
Why Is Sharps Technology (STSS) Stock Up 21% Today?
Via InvestorPlace
Why Is BioRestorative Therapeutics (BRTX) Stock Up 42% Today?
Via InvestorPlace
Dow Tumbles Over 100 Points; US Producer Prices Decline In May
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.